Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of the American Pharmacists Association : Japha|June 23, 2014
Nutrition-drug interactions: a Web-based approach to pharmaceutical care in GreeceMaria Skouroliakou, Maria-Nikoleta Thanopoulos, Giorgos Maravelias, et al.Molecular Informatics|July 29, 2016
Conformational Properties and Energetic Analysis of Aliskiren in Solution and Receptor SiteAggeliki Politi, Georgios Leonis, Haralambos Tzoupis, et al.Biochimica Et Biophysica Acta|June 20, 2014
The application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartanDimitrios Ntountaniotis, Tahsin Kellici, Andreas Tzakos, et al.Journal of Biomolecular Structure & Dynamics|April 7, 2020
Charting the structural and thermodynamic determinants in phenolic acid natural product - cyclodextrin encapsulationsIoannis Andreadelis, Μaria V Chatziathanasiadou, Dimitrios Ntountaniotis, et al.The Journal of Physical Chemistry. B|October 5, 2018
Comparative Perturbation Effects Exerted by the Influenza A M2 WT Protein Inhibitors Amantadine and the Spiro[pyrrolidine-2,2'-adamantane] Variant AK13 to Membrane Bilayers Studied Using Biophysical Experiments and Molecular Dynamics SimulationsAthina Konstantinidi, Nikolaos Naziris, Maria Chountoulesi, et al.Biochimica Et Biophysica Acta|August 17, 2011
Thermal, dynamic and structural properties of drug AT1 antagonist olmesartan in lipid bilayersDimitrios Ntountaniotis, Gregor Mali, Simona Golic Grdadolnik, et al.Combinatorial Chemistry & High Throughput Screening|May 31, 2014
An efficient synthetic method and theoretical calculations of olmesartan methyl ether: study of biological function of AT1 antagonismDimitrios Ntountaniotis, George Agelis, Amalia Resvani, et al.Combinatorial Chemistry & High Throughput Screening|March 10, 2015
Rational drug design paradigms: the odyssey for designing better drugsTahsin Kellici, Dimitrios Ntountaniotis, Eleni Vrontaki, et al.Chemical Biology & Drug Design|July 22, 2020
Antihypertensive activity and molecular interactions of irbesartan in complex with 2-hydroxypropyl-β-cyclodextrinGeorgios Leonis, Eirini Christodoulou, Dimitrios Ntountaniotis, et al.Current Medicinal Chemistry|November 18, 2015
Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled ReceptorTahsin F Kellici, Dimitrios Ntountaniotis, Eftichia Kritsi, et al.Pageof 3